Schwarz, Markus

Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4

Psychiatric GWAS Consortium Bipolar Disorder Working Group, Sklar, P., Ripke, S., Scott, L. J., Andreassen, O. A., Cichon, S., Craddock, N., Edenberg, H. J., Nurnberger, J. I., Rietschel, M., et al. (2011) · Nature Genetics

Bipolar Disorder and TreatmentGenetic Associations and Epidemiology

Cited by 1,344

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry

Treatment of Major DepressionTryptophan and brain disorders

Cited by 794

A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder

Baum, A. E., Akula, N., Cabanero, M., Cardona, I., Corona, W., Klemens, B., Schulze, T. G., Cichon, S., Rietschel, M., Nöthen, M. M., et al. (2008) · Molecular Psychiatry

Bipolar Disorder and TreatmentGenetic Associations and Epidemiology

Cited by 700

The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

Müller, N., & Schwarz, M. J. (2007) · Molecular Psychiatry

Tryptophan and brain disordersTreatment of Major Depression

Cited by 670

Genome-wide association study reveals two new risk loci for bipolar disorder

Mühleisen, T. W., Leber, M., Schulze, T. G., Strohmaier, J., Degenhardt, F., Treutlein, J., Mattheisen, M., Forstner, A. J., Schumacher, J., Breuer, R., et al. (2014) · Nature Communications

Bipolar Disorder and TreatmentGenetic Associations and Epidemiology

Cited by 346

Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice

Tolba, R., Kraus, T., Liedtke, C., Schwarz, M., & Weiskirchen, R. (2015) · Laboratory Animals

Carcinogens and Genotoxicity AssessmentLiver physiology and pathology

Cited by 313

Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder

Cichon, S., Mühleisen, T. W., Degenhardt, F. A., Mattheisen, M., Miró, X., Strohmaier, J., Steffens, M., Meesters, C., Herms, S., Weingarten, M., et al. (2011) · The American Journal of Human Genetics

Bipolar Disorder and TreatmentGenetic Associations and Epidemiology

Cited by 286

Neural and Behavioral Responses to Tryptophan Depletion in UnmedicatedPatients With Remitted Major Depressive Disorder and Controls

Neumeister, A., Nugent, A. C., Waldeck, T., Geraci, M., Schwarz, M., Bonne, O., Bain, E. E., Luckenbaugh, D. A., Herscovitch, P., Charney, D. S., et al. (2004) · Archives of General Psychiatry

Tryptophan and brain disordersTreatment of Major Depression

Cited by 273

Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression.

Neumeister, A., Konstantinidis, A., Stastny, J., Schwarz, M. J., Vitouch, O., Willeit, M., Praschak-Rieder, N., Zach, J., de Zwaan, M., Bondy, B., et al. (2002) · Archives of General Psychiatry

Neurotransmitter Receptor Influence on BehaviorTryptophan and brain disorders

Cited by 223

Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls

Neumeister, A., Hu, X.-Z., Luckenbaugh, D. A., Schwarz, M., Nugent, A. C., Bonne, O., Herscovitch, P., Goldman, D., Drevets, W. C., & Charney, D. S. (2006) · Archives of General Psychiatry

Neurotransmitter Receptor Influence on BehaviorTryptophan and brain disorders

Cited by 161

Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism-effects of medication

Oades, R. D., Dauvermann, M. R., Schimmelmann, B. G., Schwarz, M. J., & Myint, A.-M. (2010) · Behavioral and Brain Functions

Attention Deficit Hyperactivity DisorderTryptophan and brain disorders

Cited by 151

Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression

Nikkheslat, N., Zunszain, P. A., Horowitz, M. A., Barbosa, I. G., Parker, J. A., Myint, A.-M., Schwarz, M. J., Tylee, A. T., Carvalho, L. A., & Pariante, C. M. (2015) · Brain Behavior and Immunity

Stress Responses and CortisolCardiac Health and Mental Health

Cited by 147

Neuropsychiatric disorders related to interferon and interleukins treatment

Myint, A. M., Schwarz, M. J., Steinbusch, H. W. M., & Leonard, B. E. (2009) · Metabolic Brain Disease

Tryptophan and brain disordersTreatment of Major Depression

Cited by 116

Anti-inflammatory treatment in schizophrenia

Müller, N., Myint, A.-M., Krause, D., Weidinger, E., & Schwarz, M. J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Tryptophan and brain disordersSchizophrenia research and treatment

Cited by 89

Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome

Russell, A., Hepgul, N., Nikkheslat, N., Borsini, A., Zajkowska, Z., Moll, N., Forton, D., Agarwal, K., Chalder, T., Mondelli, V., et al. (2019) · Psychoneuroendocrinology

Fibromyalgia and Chronic Fatigue Syndrome ResearchLong-Term Effects of COVID-19

Cited by 83

Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder

Mühleisen, T. W., Mattheisen, M., Strohmaier, J., Degenhardt, F., Priebe, L., Schultz, C. C., Breuer, R., Meier, S., Hoffmann, P., Rivandeneira, F., et al. (2012) · Schizophrenia Research

Schizophrenia research and treatmentBipolar Disorder and Treatment

Cited by 80

Tryptophan Metabolism and Immunogenetics in Major Depression: A Role for Interferon-γ Gene

Myint, A. M., Bondy, B., Baghai, T. C., Eser, D., Nothdurfter, C., Schüle, C., Zill, P., Müller, N., Rupprecht, R., & Schwarz, M. J. (2013) · Brain, Behavior, and Immunity

Tryptophan and brain disordersTreatment of Major Depression

Cited by 74

Psychotropic Effects of COX-2 Inhibitors - A Possible New Approach for the Treatment of Psychiatric Disorders

Müller, N., Riedel, M., & Schwarz, M. J. (2004) · Pharmacopsychiatry

Tryptophan and brain disordersInflammatory mediators and NSAID effects

Cited by 71

Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130

Stübner, S., Schön, T., Padberg, F., Teipel, S. J., Schwarz, M. J., Haslinger, A., Buch, K., Dukoff, R., Lasser, R., Müller, N., et al. (1999) · Neuroscience Letters

Tryptophan and brain disordersCytokine Signaling Pathways and Interactions

Cited by 59

Tryptophan Depletion and Emotional Processing in Healthy Volunteers at High Risk for Depression

Feder, A., Skipper, J., Blair, J. R., Buchholz, K., Mathew, S. J., Schwarz, M., Doucette, J. T., Alonso, A., Collins, K. A., Neumeister, A., et al. (2011) · Biological Psychiatry

Tryptophan and brain disordersNeurotransmitter Receptor Influence on Behavior

Cited by 44

Increased Soluble Interleukin-2 Receptor Levels Are Related to Somatic but Not to Cognitive-Affective Features in Major Depression

Euteneuer, F., Schwarz, M. J., Dannehl, K., Hartung, A., Westermann, S., & Rief, W. (2012) · Brain, Behavior, and Immunity

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 25